Interventional Oncology Market Demand: Minimally Invasive Treatment Trends

According to FutureWise analysis the market for Interventional Oncology in 2023 was US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%.

Interventional oncology involves the use of image guidance to perform minimally invasive medical procedures for the diagnosis, palliation, and treatment of various types of cancer. Techniques such as fluoroscopy, ultrasound, and computed tomography are employed in these procedures to target specific areas affected by cancer or pain. Interventional oncology is often combined with other cancer treatments, including chemotherapy, radiation therapy, and surgery. These procedures offer several advantages, such as shorter hospital stays, quicker recovery times, more precise treatments, and minimal side effects. Recent technological advancements in interventional oncology, the benefits of minimally invasive surgical procedures, and increased government funding have all contributed to the growth of this market. 

The market itself can be categorized into several segments, including embolization devices, non-radioactive embolic agents, ablation devices, support devices, and guidewires. The ablation devices segment is further divided into radiofrequency ablation devices, microwave ablation devices, and cryoablation devices. Among these, the embolization devices segment is expected to register significant compound annual growth (CAGR) during the forecast period. 

Embolization is particularly favored worldwide due to its multiple benefits. This process involves the introduction of an embolus into the bloodstream to block the blood supply to the tumor, effectively occluding the blood vessels either through irradiation or chemical techniques.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=2336%20&type=requestsample

Interventional Oncology Market Segmentation:

By Product

• Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Embolic Agents
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
• Support Devices
  • Microcatheters
  • Guidewires

By Procedure

• Thermal Tumour Ablation
• Non-thermal Tumour Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Interventional Oncology Market:

• Medtronic
• Boston Scientific
• BTG Plc.
• Terumo
• Merit Medical
• Sirtex
• Ethicon
• Cook Medical
• Teleflex
• HealthTronics
• MedWaves Medical
• IceCure Medical
• Interface Biomaterial BV
• Mermaid Medicals
• ABK Biomedical
• Guerbet
• Endo Shape
• Instylla
• Shape Memory Medical
• Monteris Medical
• Trisalus Lifesciences

Buy Now the Latest Version of this Report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=2336&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Interventional Oncology Market By Product, By Procedure, By Cancer Type and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.

• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com